Evidence-Based Study to Evaluate the Clinical Effectiveness of Blue Blood Cells for Secondary Prevention in Ischemic Stroke Patients and to Expand Indications for Stroke Sequelae
SPONSOR KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE (MINISTRY OF HEALTH AND WELFARE)
PERIOD 2022.04.01-2026.11.30
Estimating Short-Term and Long-Term Direct Economic Burden Associated with OOO in South Korea
SPONSOR Global Pharmaceutical Company
PERIOD 2019.11.20-2025.12.31
Economic Analysis of OOO for the Treatment of OOO in Korea
SPONSOR Global Pharmaceutical Company based in Korea
PERIOD 2021.11.12-2025.12.31
Nationwide Healthcare Database Analysis Study of clinical and economic burden of OOO in Korea
PERIOD 2022.11.10-2025.12.31
SPONSOR
PERIOD 2023.05.15-2026.08.31
A Research on disease burden of patients with ooo in Korea
PERIOD 2022.12.28-2025.12.31
PERIOD 2021.11.26-2025.12.31
Clinical characteristics of OOO with OOO via health insurance claims data
PERIOD 2022.03.02-2025.12.31
PERIOD 2022.04.01-2025.12.31
